A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia

Bone Marrow Transplantation

Volumn 20, Issue 12, 1997, Pages 1109-1110

  Kapelushnik, J ^a   Or, R ^a   Slavin, S ^a   Nagler, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Bone marrow transplantation; Engraftment; Fanconi's anemia; Fludarabine; Toxicity

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL PROTOCOL; DRUG TOLERABILITY; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; MYELOBLAST; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTOPENIA;

EID: 0031436199     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701016     Document Type: Article

References (13)

1. Hows JM, Chapple M, Marsh JCW et al. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89. Bone Marrow Transplant 1989; 4: 629-634.
2. Kohil-Kumar M, Morris C, DeLaat C et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050-2054.
3. Zanis-Neto J, Riberio RC, Medeiros C et al. Bone marrow transplantation for patients with Fanconi anemia a study of 24 cases from a single institution. Bone Marrow Transplant, 1994; 15: 293-298.
4. Gluckman E, Auerbach AD, Horowitz MM er al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86: 2856-2862.
5. Giralt S, Estey E, van Besien K et al. Engraftment of allogeneic (allo) stem cells with purine analog containing non-myeloablative regimens for induction of graft-versus-leukemia. Exp Hematol 1996; 24 (Suppl. 9): 1046 (Abstr.).
6. Khouri I, Keating MJ, Przepiorka D el al. Engraftment and induction of GVL with fludarabine (FAMP)-based nonablative preparative regimen in patients with chronic lymphocytic leukemia (CLL) and lymphoma. Exp Hematol 1996; 88 (Suppl. 9): 301a (Abstr.).
7. Slavin S, Nagler A. Naparstek E et al. Immunotherapy of leukemia in conjuction with nonmyeloablative conditioning: engraftment of blood stem cells and eradication of host leukemia with nonmyeloablative conditioning based on fludarabine and anti-thymocyte globulin (ATG). Blood 1996; 88 (Suppl. 1): 614a.
8. Hiddemann W, Unterhalt M, Pott C et al. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German low grade non-Hodgkin's lymphoma study group. Semin Oncol 1993; 20: 28-31.
9. Gillis S, Dann EJ, Cass Y et al. Activity of fludarabine in refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma - the Jerusalem experience. Leuk Lymphoma 1993; 15: 173-176.
10. Avramis VI, Champagne J, Sato J et al. Pharmacology of fludarabine phosphate after phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res 1990; 50: 7226-7231.
11. Strathdee CA, Buchwald M. Molecular and cellular biology of Fanconi anemia. Am J Hematol/Oncol 1992; 14: 177-185.
12. Flowers MED, Zanis J, Pasquini R et al. Marrow transplantation for Fanconi anemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol 1996; 92: 699-706.
13. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation. New Engl J Med 1997; 336: 897-904.